These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Pulmonary embolism: what happens to the emboligenic focus?]. Serradimigni A; Philip F; Elias A; Lecorff G Haemostasis; 1986; 16 Suppl 4():69-78. PubMed ID: 3770559 [No Abstract] [Full Text] [Related]
7. Thrombolytic drugs: quo vadis? Verstraete M Acta Clin Belg; 1977; 32(6):434-9. PubMed ID: 616754 [No Abstract] [Full Text] [Related]
13. Fibrinolytic agents. Schmitz-Huebner U; van de Loo J Clin Haematol; 1981 Jun; 10(2):481-96. PubMed ID: 7032785 [No Abstract] [Full Text] [Related]
14. Urokinase in pulmonary thromboembolic disease: a preliminary report. Dickie K; de Groot W Tex Rep Biol Med; 1967; 25(4):613-24. PubMed ID: 6082233 [No Abstract] [Full Text] [Related]
15. Fibrinolysis and its current usage. Rubin RN Clin Ther; 1983; 5(3):211-22. PubMed ID: 6342782 [TBL] [Abstract][Full Text] [Related]
16. Current thoughts on venous thromboembolism. Browse NL Surg Clin North Am; 1974 Feb; 54(1):229-38. PubMed ID: 4814520 [No Abstract] [Full Text] [Related]
17. [Fibrinolytic therapy. Indications and execution]. Trübestein G Dtsch Med Wochenschr; 1985 Sep; 110(37):1417-9. PubMed ID: 4028995 [No Abstract] [Full Text] [Related]
18. [The thrombolytic medications]. Rignault D Presse Med (1893); 1969 Jan; 77(2):55-8. PubMed ID: 4239477 [No Abstract] [Full Text] [Related]
19. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases]. Verstraete M Clin Ter; 1975 Jun; 73(5):403-22. PubMed ID: 1139864 [No Abstract] [Full Text] [Related]